The natural biological transition of menopause, once a private milestone in a woman’s life, has been transformed into a high-stakes commercial frontier and a medicalized "emergency." As the "wellness" industry expands, experts are sounding the alarm on "meno-washing"—the practice of rebranding everyday products at premium prices—and a healthcare trend that reflexively prescribes psychiatric medications for what are often normal life transitions or external social stressors.
Main Facts: The Rise of the Menopause Industrial Complex
Sarah White, Chief Executive Officer of Jean Hailes for Women’s Health, has observed a troubling shift in her clinics. Increasingly, younger women in their 30s and early 40s are arriving with a self-diagnosis of perimenopause, attributing a wide array of physical and emotional symptoms to the hormonal transition. While perimenopause can begin as early as 30, it typically does not manifest until the mid-40s. White argues that this "narrow focus" is distracting clinicians and patients from other underlying health issues or life stressors.
The core of the issue lies in the "medicalization" of a natural process. By framing menopause as a "devastating medical emergency," commercial entities have created what researchers call a "hot flush gold rush." This has led to:
- The proliferation of "meno-washing": Marketing ordinary products—such as tea, chocolate, and socks—as specialized menopause treatments at inflated prices.
- Over-medicalization: The reflexive prescription of Hormone Replacement Therapy (HRT) and antidepressants (SSRIs/SNRIs) for symptoms that may not be hormonal in origin.
- The "200 Symptom" Myth: While science clearly links only two symptoms—vaginal dryness and vasomotor symptoms (hot flashes)—to menopause, marketers have ascribed nearly 200 different ailments to the transition to expand their consumer base.
Chronology: From Taboo to Trend
For decades, menopause was a "silent" transition, often ignored by medical research and stigmatized in popular culture. This neglect created a genuine "knowledge gap" in women’s health.
In the last decade, however, the narrative shifted. Social media and a new wave of "fem-tech" startups began to break the silence. While increased awareness was initially seen as progress, Sarah White—who previously served as the director of the Australian tobacco control program, Quit—notes that the narrative was quickly hijacked.
"I could just see these companies who were trying to hijack a narrative online," White explains. Much like the tobacco industry’s historical attempts to frame products as "safe" or "liberating," the menopause industry has utilized social media algorithms to amplify fear and distress. Because algorithms favor high-emotion content, negative portrayals of menopause—women "fanning themselves or passing out," as Professor Martha Hickey puts it—have become the dominant imagery, overshadowing the many women who transition with minimal disruption.
Supporting Data: The High Cost of Pathologization
The consequences of this trend are not merely financial; they are deeply clinical. When menopause is treated as a disease rather than a life stage, the medical response often defaults to pharmaceutical intervention.
The Antidepressant Surge
Data from the United States indicates that women are 2.5 times more likely to use antidepressants than men, with usage peaking in women aged 40 to 50. Women over 45 are nearly twice as likely to be diagnosed with anxiety disorders and 1.5 times as likely to be diagnosed with depressive disorders compared to men of the same age.
While these drugs are sometimes used to treat hot flashes in women who cannot take hormones, they carry significant risks. Middle-aged women are uniquely vulnerable to side effects that antidepressants can exacerbate, including:
- Increased risk of bone fractures.
- Higher incidence of cardiovascular events.
- Severe withdrawal syndromes upon cessation.
The Myth of the "Productivity Cliff"
To sell corporate "menopause-friendly" training packages, some companies have promoted the idea that menopausal women are on the verge of a "productivity cliff." However, research published in The Lancet refutes this, showing that middle-aged women are a highly productive subpopulation. Pathologizing their biology in the workplace can inadvertently foster ageist and sexist biases among employers.
Cultural Variation and the "Self-Fulfilling Prophecy"
Research suggests that a woman’s expectations of menopause significantly predict the severity of her symptoms. A 2009 study comparing Indian women in Delhi, Indian migrants in the UK, and White British women found that symptoms were more closely tied to the country of residence than ethnicity. Women in the UK, where menopause is heavily medicalized, reported significantly higher rates of hot flashes than their counterparts in India.
Similarly, in cultures where menopause is viewed positively—such as China, where it is called the "Second Spring"—women report lower levels of distress and fewer physiological symptoms.
Official Responses: Expert Perspectives on "Meno-Washing"
Experts across sociology, marketing, and medicine are calling for a radical shift in how we discuss and treat the transition.
Sarah White (CEO, Jean Hailes):
White, who serves on the Women’s Health Products Working Group for Australia’s Therapeutic Goods Administration (TGA), is particularly critical of the "crap" being sold to women. "It makes me a bit mad that we have people leveraging this gap… not to actually see policy change and research change, but to sell crap," she says. She advocates for being "prepared, but not scared."
Professor Martha Hickey (University of Melbourne):
Hickey emphasizes that the medical community must be honest about what menopause actually causes. "Hormonal treatments work for hot flushes and night sweats. That’s pretty much it," she notes. She compares the transition to pregnancy: it is a normal biological event that usually goes fine, but requires targeted medical help only when it "goes wrong."
Emine Öncüler Yayalar (Sociologist) and Ayse Öncüler (Marketing Researcher):
In their research on menopause marketing, the Öncülers identified two dominant (and contradictory) messages: "Empowerment" and "Care." While these sound positive, the researchers argue they place the entire burden on the individual woman to "optimize" her body and "choose correctly" among a sea of commercial products, rather than addressing the structural issues women face.
Implications: Addressing the "Midlife Collision"
The most significant danger of the current menopause craze is that it provides a "biological band-aid" for what are often social and structural problems. Researchers have coined the term "Midlife Collision" to describe the unique pressures women face in their 40s and 50s, including:
- The "Sandwich Generation" Burden: Simultaneously caring for elderly parents and adolescent children.
- Workplace Ageism: Gendered ageism that limits career advancement just as women reach their peak expertise.
- Financial Stress: Navigating the economic pressures of looming retirement.
- Structural Racism: Research shows Black women in the U.S. experience more frequent and long-lasting vasomotor symptoms, a phenomenon linked to the chronic stress of structural racism rather than just hormonal shifts.
The Path Forward: Education over Medication
To counter the "catastrophizing" narrative, experts suggest several key interventions:
- Unbiased Education: Developing resources free from pharmaceutical or commercial sponsorship that provide consistent, evidence-based information.
- Cognitive Behavioral Therapy (CBT): Promoting CBT as a tool to help women manage the emotional and mental response to symptoms like hot flashes, breaking the cycle of catastrophizing.
- Structural Reform: Shifting the focus from "pills for menopause" to social changes, such as better support for caregivers and more flexible, non-stigmatizing workplace policies.
- Reframing the Narrative: Highlighting the "massive positives" of post-menopause, such as the end of menstruation and contraception concerns.
As Sarah White concludes, the goal should not be to dismiss women’s suffering, but to ensure that the "answer" isn’t always a product or a prescription. "It’s the structural things we need to change, not just taking a pill that’s suddenly going to make everything all right. We actually have to do some hard work around changing some social and cultural structures."
